Keywords: steady, sales, growth, chugai, pharma, japanese, drugmaker
STEADY SALES GROWTH FOR CHUGAI PHARMA
Article | 07 March 1994
Japanese drugmaker Chugai Pharmaceutical posted sales of 151.4 billion yen ($1.44 billion) for the year ended December 1993, with operating profits up 11% at 17.5 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
